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 Introductions: Kidney biopsy is the standard tool to diagnose glomerular 
disease (GD). There is lack of national registry of kidney biopsy for the 
type, incidence and prevalence of GD. We aim to review kidney biopsy at 
Patan Hospital for profile of GD in local scenario. 
 
Methods: This was a chart review of patients who underwent kidney 
biopsy at Patan Hospital, Nepal, from October 2013 to September 2015. 
We analyzed the data for indication of kidney biopsy, types of GD and 
complication of biopsy.  
 
Results: There were 117 patients who had kidney biopsies. 
Immunoglobulin A Nephropathy was seen in 42 (35.8%) and Lupus 
Nephritis in 38 (32.5%). Sub nephrotic range proteinuria with or without 
active urinary sediments was found in 75 (64%). Blood transfusion was 
required in 3 (2.5%) patients after biopsy. There was no surgical 
intervention or mortality related to biopsy. 
 
Conclusions: IgA Nephropathy was the commonest glomerular disease. 
Kidney biopsy was a safe and effective procedure. 
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The incidence and prevalence of kidney 
disease varies, with Immunoglobulin A 
nephropathy (IgA N) as the leading cause of 
glomerular disease (GD) worldwide1 and GD is 
the third most common cause of end stage 
renal disease.2 Kidney biopsy is the gold 
standard to diagnose, and provide guidance for 
the specific treatment and prognosis.3 Data on 
type, incidence of GD is lacking locally. We also 
do not have national biopsy registry. This study 
aims to find out the types of renal diseases 






This was a chart review of patients who 
underwent kidney biopsies at Patan Hospital, 
Patan Academy of Health Sciences, Lalitpur, 
Nepal, from October 2013 to September 2015. 
Biopsies were done by nephrologist using Bard 
gun after ultrasound marking of the kidneys. 
Children under the age of 10 years were given 
intravenous anaesthesia by anaesthesiologist 
and biopsy taken under real time ultrasound 
guidance. The biopsy tissue was sent to India 
for light microscopic and immunofluorescent 
examination. The demographics of the patients 
(age, sex), 24-hour urine protein, indication for 
biopsy and post procedural complication were 
recorded and analysed by SPSS 20. Indication 
of renal biopsy was classified as sub nephrotic 
range in patients with <3g/day of proteinuria 





Total 117 patients’ biopsy data were eligible 
for analysis (five were excluded out of 122 
biopsies due to insufficient tissue yield). 
Female were 70 (59%) and male 47 (41%), age 
3 to 79 years, (Figure 1). 
 
Sub nephrotic range proteinuria with or 
without active urinary sediment was the 
indication for biopsy in 75 (64%). Nephrotic 
range proteinuria was seen in 42 (36%). The 
IgA N was seen 42 (35.8%), eight of them had 
crescent formation. Lupus Nephritis (LN) was 
seen in 38 (32.5%), 20 (52.5%) class IV LN as 
per International Society of Nephrology (ISN) 
pathological classification. Focal Segmental 
Glomerulosclerosis (FSGS) was 11 (9.4%), 
(Table 1). 
 
We had 8 (6.8%) postpartum biopsy in patients 
with nephrotic range proteinuria during 
pregnancy, (Figure 2). Three (37.5%) of them 
were IgA N with crescent formation and had 
impaired renal function. 
 
Three patients had bleeding after procedure 
and needed blood transfusion. There was no 





Our study showed that IgA N was the most 
common type of nephropathy. Studies done in 
china,8,9 Australia,10 United Sates,1 have 
reported similar findings. 
 
Other studies done in Nepal reports mixed 
results. Kafle et al. reports LN (20.6%) was the 
leading cause followed by FSGS (19.6%), and 
IgA N (9.8%) during the year 2007-9, compared 
to more membranous glomerulonephritis 
(42.3%) and cause and only few cases of IgA N 
(2.9%) and LN (1.5%) in earlier years.4 Also 
from Nepal, Ghimire et al. in their analysis of 
data from year 2011 to 2012 showed more 
cases of meningoproliferative 
glomerulonephritis (24%) followed by Minimal 
change disease (21.3%), LN (13.3%) and IgA N 
(6.7%).5 These reports may be a reflection of 
changing pattern of renal disease locally. Our 
findings of 64% female, and overall 89% 
patients below the age of 50 years is in line 
with other reports locally from Nepal reporting 
young age and female preponderance. The ISN 
class IV lupus nephritis (52.5%) was the 
commonest type of LN.7 
 
Different studies from Nepal report different 
findings. There is a need for national biopsy 
registry to find the type, incidence and 
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Table 1. Kidney biopsy diagnoses findings patients with renal disease who had kidney biopsy  (n=117) 
 
 
Histological diagnosis Number  Percentage  
Immunoglobulin A nephropathy (IgA N) 42  8 crescents 34.43%  
Lupus Nephritis 38   31.15%  
Focal Segmental Glomerulosclerosis (FSGS) 11   9.02%  
Membranous Glomerulopathy  7   5.74%  
Membranoproliferative Glomerulonephritis 5   4.10%  
Minimal Change Disease 5   4.10%  
Post infectious Glomerulonephritis 4   3.28%  
Diabetic Nephropathy 2   1.64%  
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Kidney biopsy is a safe procedure and can be 
done as an outpatient procedure. Bleeding is  
 
 
the common and life-threatening complication 
associated with kidney biopsy.11-12 We had 3  
 
(2.5%) patients with bleeding who required 
blood transfusion. No surgical intervention was 
needed and we had no mortality associated 
with the procedure. 
CONCLUSIONS 
 
The kidney biopsy revealed Immunoglobulin A 
nephropathy (IgA N) as the leading cause of 
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